India-EU trade deal threatens access to cheap, generic drugs
A free trade agreement is being negotiated between India and the EU which could restrict access to generic drugs in the developing world. MSF outlines that India is the source of 80% of antiretrovirals in developing countries. The draft agreement would strengthen intellectual property and enforcement, making access to affordable ARVs much more difficult.
BMJ 2010;340:c2309